> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Drug Compounding Panel Discussing 4 Bulk Drugs
- URL: https://www.fdaweb.com/drug-compounding-panel-discussing-4-bulk-drugs/
- Published: 2022-05-09T12:00:00.000Z
- Updated: 2026-09-14T17:43:54.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151768

*Federal Register* notice: FDA has announced a 6/8 Pharmacy Compounding Advisory Committee meeting. Panel members are scheduled to discuss four bulk drug substances that have been nominated to be included on the agency’s 503A Bulks List for drug compounding — ammonium tetrathiomolybdate, enclomiphene citrate, ferric subsulfate, and glutathione. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-05-06/pdf/2022-09797.pdf?ref=fdaweb.com).